Lene Dissing Sjö

Clinical Associate Professor

Member of:

Publication year:

All

1 - 2 out of 2Page size: 25

Sort by: Publication date

2019
Published
Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma
Dimopoulos, K., Fibiger Munch-Petersen, H., Winther Eskelund, C., Sjö, Lene Dissing, Ralfkiær, E., Gimsing, P. & Grønbæk, Kirsten, 2019, In: Leukemia and Lymphoma. 60, 1, p. 180-188
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Orbital Lymphoma - An International Multicenter Retrospective Study
Olsen, T. G., Holm, F., Mikkelsen, Lauge Hjorth, Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Sjö, Lene Dissing, Vemuganti, G. K., Thuro, B. A. & Heegaard, Steffen, 2019, In: American Journal of Ophthalmology. 199, p. 44-57 14 p.
Research output: Contribution to journal › Journal article › Research › peer-review

ID: 6945

381 downloads
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Research output: Contribution to journal › Journal article › Research
Published
200 downloads
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
Research output: Contribution to journal › Journal article › Research › peer-review
Published
127 downloads
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
Research output: Contribution to journal › Journal article › Research › peer-review
Published